HRS Co., Ltd (KOSDAQ:036640)
5,070.00
-10.00 (-0.20%)
At close: Mar 27, 2026
HRS Co., Ltd Revenue
In the year 2025, HRS Co., Ltd had annual revenue of 78.91B KRW, down -1.65%. HRS Co., Ltd had revenue of 19.04B in the quarter ending December 31, 2025, a decrease of -1.14%.
Revenue
78.91B
Revenue Growth
-1.65%
P/S Ratio
1.03
Revenue / Employee
496.29M
Employees
159
Market Cap
81.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 78.91B | -1.32B | -1.65% |
| Dec 31, 2024 | 80.23B | 2.07B | 2.64% |
| Dec 31, 2023 | 78.17B | -7.93B | -9.21% |
| Dec 31, 2022 | 86.10B | 2.03B | 2.42% |
| Dec 31, 2021 | 84.06B | 16.66B | 24.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cosmax Nbt | 287.48B |
| Jeil M&S | 202.36B |
| JUNGDAWN | 160.88B |
| Green Cross Medical Science | 108.41B |
| Wysiwyg Studios | 106.13B |
| Tplex | 93.85B |
| Icure Pharmaceutical Incorporation | 93.22B |
| GIANTSTEP | 41.06B |